ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 228 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2023. The put-call ratio across all filers is 5.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $3,537 | +22.4% | 459,482 | +66.8% | 0.00% | 0.0% |
Q4 2023 | $2,890 | +60.7% | 275,542 | +101.4% | 0.00% | 0.0% |
Q3 2023 | $1,798 | -19.0% | 136,809 | -22.3% | 0.00% | 0.0% |
Q2 2023 | $2,221 | -21.7% | 176,074 | -18.9% | 0.00% | 0.0% |
Q1 2023 | $2,835 | -23.3% | 217,132 | +3.7% | 0.00% | -50.0% |
Q4 2022 | $3,695 | -99.9% | 209,451 | +6.5% | 0.00% | -33.3% |
Q3 2022 | $2,997,000 | +43.1% | 196,735 | +39.2% | 0.00% | +200.0% |
Q2 2022 | $2,095,000 | -49.2% | 141,290 | -22.8% | 0.00% | -66.7% |
Q1 2022 | $4,120,000 | -60.2% | 183,011 | -67.4% | 0.00% | +50.0% |
Q4 2021 | $10,354,000 | +177.5% | 561,108 | +101.1% | 0.00% | 0.0% |
Q3 2021 | $3,731,000 | +54.9% | 279,007 | +114.4% | 0.00% | +100.0% |
Q2 2021 | $2,408,000 | -32.7% | 130,123 | -45.4% | 0.00% | -50.0% |
Q1 2021 | $3,580,000 | +40.1% | 238,414 | +34.8% | 0.00% | +100.0% |
Q4 2020 | $2,555,000 | +58.7% | 176,874 | -10.5% | 0.00% | 0.0% |
Q3 2020 | $1,610,000 | +16.8% | 197,606 | -3.0% | 0.00% | 0.0% |
Q2 2020 | $1,379,000 | +155.8% | 203,696 | +166.0% | 0.00% | – |
Q1 2020 | $539,000 | -71.9% | 76,571 | -60.8% | 0.00% | -100.0% |
Q4 2019 | $1,917,000 | +35.4% | 195,423 | +51.6% | 0.00% | 0.0% |
Q3 2019 | $1,416,000 | -18.5% | 128,927 | -13.7% | 0.00% | 0.0% |
Q2 2019 | $1,737,000 | +237.9% | 149,366 | +177.3% | 0.00% | – |
Q1 2019 | $514,000 | -5.9% | 53,870 | -4.8% | 0.00% | – |
Q4 2018 | $546,000 | -74.6% | 56,591 | -62.5% | 0.00% | -100.0% |
Q3 2018 | $2,151,000 | +86.9% | 150,974 | +57.3% | 0.00% | 0.0% |
Q2 2018 | $1,151,000 | -16.5% | 95,965 | -14.0% | 0.00% | 0.0% |
Q1 2018 | $1,379,000 | -55.6% | 111,559 | -47.8% | 0.00% | -66.7% |
Q4 2017 | $3,107,000 | -32.1% | 213,650 | -33.6% | 0.00% | -40.0% |
Q3 2017 | $4,578,000 | -13.6% | 321,746 | -22.5% | 0.01% | -16.7% |
Q2 2017 | $5,298,000 | +7.4% | 415,211 | +6.7% | 0.01% | +20.0% |
Q1 2017 | $4,934,000 | +18.8% | 389,123 | -4.3% | 0.01% | +25.0% |
Q4 2016 | $4,153,000 | +515.3% | 406,731 | +693.6% | 0.00% | – |
Q3 2016 | $675,000 | -54.9% | 51,254 | -56.5% | 0.00% | -100.0% |
Q2 2016 | $1,497,000 | +97.0% | 117,850 | +101.3% | 0.00% | +100.0% |
Q1 2016 | $760,000 | +49.9% | 58,556 | +73.2% | 0.00% | 0.0% |
Q4 2015 | $507,000 | -87.3% | 33,810 | -89.8% | 0.00% | -80.0% |
Q3 2015 | $3,988,000 | +281.6% | 332,294 | +313.5% | 0.01% | +400.0% |
Q2 2015 | $1,045,000 | +1766.1% | 80,352 | +1474.0% | 0.00% | – |
Q1 2015 | $56,000 | -86.0% | 5,105 | -84.7% | 0.00% | – |
Q4 2014 | $401,000 | -37.3% | 33,359 | -32.2% | 0.00% | – |
Q3 2014 | $640,000 | -55.7% | 49,185 | -45.5% | 0.00% | -100.0% |
Q2 2014 | $1,444,000 | +57.5% | 90,171 | +77.3% | 0.00% | 0.0% |
Q1 2014 | $917,000 | -19.6% | 50,857 | -33.0% | 0.00% | 0.0% |
Q4 2013 | $1,141,000 | -29.9% | 75,943 | -34.7% | 0.00% | -50.0% |
Q3 2013 | $1,628,000 | +128.3% | 116,375 | +111.3% | 0.00% | – |
Q2 2013 | $713,000 | – | 55,084 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |